FORWARD Study1

This multicenter, prospective, single-arm, observational post-market study evaluated the safety and performance of the Evolut™ R system in a routine hospital setting.

  • Study Status/Duration: 12-month outcomes reported/3-year follow-up
  • Sample Size: N = 1040
  • Devices: Evolut™ R TAV


30-day procedural outcomes



ADVANCE Study2

ADVANCE is a multicenter, prospective, single-arm, observational study to evaluate safety and performance of the CoreValve™ system in a routine clinical setting.

Study Status/Duration: 5-year outcomes reported/5-year follow-up
Sample Size: N = 1,015
Devices: CoreValve, TAV




Key Medtronic trials

Review the latest data supporting the Evolut™ platform.

Procedure and performance

Discover our procedural guidance and outcomes you can expect from the Evolut™ platform.

Build your knowledge.

Medtronic Academy offers a wide range of resources for the Evolut™ TAVI platform.


Related products